Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use of our report dated March 6, 2023, with respect to the consolidated financial statements of Stoke Therapeutics, Inc., incorporated herein by reference.
| /s/ KPMG LLP |
Boston, Massachusetts
April 13, 2023
